Member Info for news

Octopus Investments Nominees Ltd - Link https://beta.companieshouse.co.uk/company/05572093/officers

Paul Stephen, LATHAM {Director} - per Co*s House as above.

On Linkedin [Open file], Mr Paul Stephen Latham is the Managing Director of Octopus Investments Nominees Ltd.
"2012- VENTURE CAPITAL TRUST MANAGER OF THE YEAR- Won almost every year for 9 YEARS."
"SUNDAY TIMQES 100 Best Companies to Work For."

Note: Please check by putting the above name into the search engine at Linkedin.

Found Octopus Investment Nominees as its under Companies House. I checked one of the directors ie PARISHA KANANI.
According to Bloomberg, Parisha Kanani is Secretary of Octopus Titan VCT 4 Plc.
Parisha Kanani also turns up as Associate General Counsel at Jefferies & Co [University of London]

Note: All can be checked via putting the said names into the search engine. Please check. I have not checked the other directors yet. As far as is commonly known, VCT stands for VENTURE CAPITAL ...

Today, Tues 28 Aug 2018, IMTK issued a Holdings RNS at 9.12am. It said that Octopus Investment Nominees crossed the threshold on 23 Aug 2018 to now own 18.69% in IMTK [previous 17.25%].

On 24 Aug 2018, Cannacord Genuity of Canada held 10.6773% of IMTK {small reduction}.

Therefore, between these two, it accounts for 29.29%. Note sure who Octopus are?

Pl check as there can be typo errors.

Link: www.hl.co.uk/shares There is a list of 10. Other than UKOG, the rest are FT co*s.
11:27am, Tues, 28 Aug 2018. Pl check.

10 mins ago, Tues 28 Aug 2018 https://twitter.com/OilPriceHourly

On topic for UKOG plc whose oil is Brent.

FBDU 6 Aug 2018 RNS: Holding: Kathleen Schmainda- Threshold crossed from 5.49% to 7.59% holding in FBDU.
[See icon RNS above this page].

Kathleen Schmainda- Linkedin [Public Open File]
"Vice Chair, Radiology Reserch, Medical College of Wisconsin: 2011 to Present."
"Education: MIT: PhD Electrical & Medical Engineering & Harvard Medical School"
"Patent: Method for detecting tumour cell invasion using short diffusion times."
"Groups: Magnetic Resonance"

Link: https://www.linkedin.com/in/kahleen-schmainda-35437814

From MCW.Edu site: "Kathleen Schmainda: PhD, Professor of Radiology & Biophysics, Imaging Science, Research Radiology.

From Grantome: "Quantative {Perfusion & Diffusion} MRI Biomarkers to measure Giloma Response: Kathleen Schmainda.

Please check. DYOR.

draft

I just happened to see the Flying Brands video interview on Twitter. I thought it would be educational. So just out of curiosity, I watched the interview. I follow Mayo Clinic and one or two other American hospitals of renown. So, when I heard the mention of Mayo Clinic, I was interested. I also think that it is helpful to patients & surgeons to be able to see where the tumour ends and where the inflamation starts per the interview. So, I have been slowly going through what I heard and following through. In general, I have to acquaint myself further as to the general market in medical imaging. I am not in the medical profession hence I have to do research layer by layer.

https://www.slb.com/services/characterization/testing/surface_testing_extended_well.test.aspx

Above link is to Schlumberger - What Extended Well Testing involves: Validation of seismic, geological & Petrophysical data, downhole & surface data acquisition, pressure gauge system, verify static data dynamically, obtain additional production related data such as water cut, sand production & well deliverability, confirm long term reservoir deliverability, pilot future facility design during actual field development, estimate reservoir deliverability ...Testing minimises risks relating to developing a field for long- term, sustained production."

Comment:
UKOG has already issued a RNS of 3 Aug 2018: "Portland high-rate flow test successfully completed." Hence, why DL has tweeted today to let the experts get on with it. So, it would appear that unless the above data and report is done, the Extended Well Test does not just merely....but more to do with the above etc per Schlumberger. Please check. DYOR.

draft

I dont normally post on any forum that I have not bought in in general - but not today. I try to do a lot of research before I buy in but it is not a large position. I try as much as possible to delve more deeply but not done it thoroughly yet. Courtesy of a reply. Kind regards.

News. Thur 23 Aug 2018

P.S.

From the FBDU 1 Aug 2018 Prospectus
Left out: Biometric Imaging at a NUMBER of hospitals & clinics.

draft

Thank you for mentioning about the latest Flying Brands Prospectus. I have managed to read quite a bit from the 109 pages.

Flying Brands 1 Aug 2018 Prospectus [109 pgs] www.flyingbrands.co.uk/publications/

1)In essence, there are 3 BioMetrics products: IB Neuro, IB Diffusion & IB DCE
The IB DCE does a WHOLE BODY approach used to monitor BREAST cancer, PROSTRATE cancer & BRAIN Cancer.

In May BioMetrics was installed full suite at the General Anti-Cancer & Oncology Hospital in Athens, Greece.
Pg 40- It was said that Biometrics is in luminary centres eg MAYO CLINIC & Barrow Neurological Institute, Arizona, USA.

It has been in PEER-REVIEWED PUBLICATIONS supporting the product. There are 3,700 active neurological surgeons.

Accelerating the sale of Imaging. Next generation....

1)STONECHECKER- "Aims to be standard medical imaging software for urolithiasis."

Comment: So not just brain but as above. Please check as there can be copying / typo errors. DYOR.

ANOTHER INTERVIEW -Flying Brands CEO, Nick Stevens with VOX Markets, also of the same period as the earlier posted with Proactive Investors.co.uk of July 2018.

Re: MAYO CLINIC & Biometrics Imaging [VOX interview & FDBU as above]
In essence, BioMetrics is "IN CLINICAL PRACTICE - MAYO CLINIC" Mentions a conference in Europe and Best Practice in Europe relating to Biometrics.

To listen to the audio interview, just put into the search engine Flying Brands plc VOX Markets and it is the top interview of July 2018.

Please check.

P.S

The FBDU interview also mentioned that the placing [done] for StoneChecker & Imaging Biometrics - latter commercialisation efforts.

Link: www.proactiveinvestors.co.uk/LON:FBDU/FlyingBrandsLtd/
FBDU Video Interview: "StoneChecker still on track for FDA clearance and commercial roll-out of software." Proactive Investor.co.uk 23.7.18

In brief:
Flying Brands: Imaging Bio Metrics {2 products: IBO Euro & Rrd/Tex]
<>MAYO CLINIC,ARIZONA, USA {IBO Euro] - Mayo Clinic using IBO Euro in their Clinical WorkFlow. Useful for their surgeons re: brain tumour, putting needles into the tumour and not missing or around it. Shows where the brain tumour ends and inflammation starts. FDA clearance.

Note: Please check as there can be errors listening and trying to copy down the details.
DYOR.

Around The KIMMERIDGE Formation Which Has Been Likened BY INDUSTRY To MAJOR OIL FIELDS in the US. One of the MOST PROMISING is the Horse Hill site at Crawley, dubbed the Gatwick Gusher after encouraging initial tests by UKOG plc. The co is undertaking a 150 day testing programme ahead of commencing drilling at the site towards the end of summer."

"UKOG hopes to be COMMERCIALLY PRODUCING oil BY Spring next year."

Note: Holmswood, Balcombe sites also mentioned. On the map shown, it marks Horse Hill, Holmswood & Broadford Bridge.

Link: https://www.theguardian.com/business/2018/mar/15/new-oil-threat-looms-over-englands-national-park-national-park-land-campaigners-warn-?CMP=share_btn_tw

From the Guardian, 15.3.18 Please check as there can be typo errors.

contd

I thought I would mention it in passing because one needs to have the total picture. There is NEVER such a thing as No Risk. It is always Risk vs Reward. On every stock, one needs to do an analysis of risk vs reward. It is not a big risk but nevertheless a risk. Otherwise, people will think one only mentions the plus but what about the risk?

As I mentioned I dont have to post on this forum as we are awaiting developments.

News travels quick on Twitter via FT, Reuters etc and there is no need to engage in long discussions.

In the past, there was another entrepreneur who wanted to invest. Again,it had to go to the regulatory body.

I have been on these forums for quite a while and we all know each other from years ago. So, everyone has a reputation and mine is news/factual wherein possible if the data is available.

I am not going to be around for long because on one of the other shares, the EWT will end before Xmas so not much more to monitor.

If Vin Murria comes into the co, it will be quite a while and nothing much to monitor or discuss as news will come via RNS. If the old pattern holds, then acquisitions will be the name of the game.

So, only at this early stage is there a need to watch.

I bid you good night. I will not be answering any more as it will be non-stop.

Do research and due diligence. At the end of the day, its one*s investment and judgment and to each, they will have to come to their own conclusion based on the news and facts.

krynap

News has been around for a long time and a lot of people know each other. I deal in facts and the RNS of 5 June 2018 does state very clearly that it has just done a raising for £225k and was going to sell the co but terminated discussions, hence the share price fell to 0.48p. Further, the co said that they need money for the business to continue. Look up any accounts of any co and see that every accounts has to be signed by the auditors to be a "going concern" which usually means it has to have 12 months cash flow.

Vin Murria is No 47 out of Tech*s 100 Richest List [link posted before or else put that into the search engine] and therefore, she does not need the money because the FT etc reported that she and her family collected just over £100million from the sale of Advanced Computer in 2014. Since leaving the University [London], she started in Kewill plc and was put in charge of 16 acquisitions. She was appointed CEO and by the time she left, Kewill plc was well over £1 billion. Vin Murria also bought stakes in Softcat and Sopheon, one of which from recall was around £1m [data from 4 Traders.com].

It is NOT me saying that if Vin decides not to carry on, there is risk - it is Share Prophets. Vin Murria has a good reputation and at the Investor Show by SP, she was introduced as the Queen of Tech. In the SP article, he said she has a "scintillating record". So public facts.

I mentioned this aspect because Vin Murria has a good reputation and received an OBE for services to the UK digital economy. Just type up her name and one can see it online. She was also one of 7 big hitters in tech considered suitable for the post of CEO of Softcat [billion £ co] but went on to be the Non-Executive Director. She is also Non-Executive Director of Zoopla which got taken over recently for billions by an American firm. She is said to have bought 10% of finnCap, a top AIM and FT broker who happens to be the Nomad to IMTK.

Vin also sits as Senior Advisor at finnCap and is Senior Advisor to NM Rothschilds. She is Partner in Elderstreet a VC firm as well as HG Capital. All on public data on Linkedin and online.

She would not like all the comments made about her - no corporate big name would like that to be attached to her name. Why? She does not need to pinch and save on a few £*s. All said, her investment ["Controlling Investment Equity] has to go to the Takeover Panel to gain permission. So all will be TRANSPARENT as the figures of how the share price is calculated + the £500,000 loan to be shown.

Quite a lot of news outlets read social media -City AM on Twitter said so today. So, if people are going to mis-read the facts and not check carefully by asking the Nomad or Takeover Panel on how the figures were worked out, it would not be good for one*s business reputation if one or two think that she is getting the share cheap etc etc.

The principle of "Fair Value" is commonly known and one can ask the Nomad to confirm.

No, I deal

contd

a few co*s on AIM that are of SMALL MKT CAPS which means that Vin has to come up WITH LESS MONEY. Some micro caps needing money are at £500k or some even less than that. One can put oneself into her shoes to say why come to a co that she is not welcomed and such things have been said of her. After all, NONE of the parties that IMTK talked to were willing to GIVE MONEY UPFRONT by way of a loan straight away of £500,000. Investors forget that the £500,000 has to be put into the calculations and then re-calculated for the amount Vin will be investing as well.

There should be no great fall in the share price except that people want the share cheap and have decided to say its x or y. Isnt that common on other stocks as well. I have been on a gold stock and everyday, its saying the share should be 1.13p. Well, yesterday, after an RNS, the gold stock went up to 1.27 - 1.29p.

Just saying.

Global_2017
On the London South East page above, the 52 wk low was 0.48p. I have just checked the 3 year London South East Share Chart and it shows that 18 June - 1 July 2018, the share price was 0.48p.

I then looked at the 5June 2018 RNS close to that time:"Strategic Review, New Funding, Board Changes & New Joint Broker."
It stated: "£225,000 of new funds raised. As announced on 29 May 2018, the directors began a Parallel Process to SEEK NEW FUNDING to enable the business TO CONTINUE FOR THE IMMEDIATE FUTURE. The board confirms that it has CLOSED the formal SALE process and TERMINATED all discussions with interested parties."

Comment: So the RNS is self explanatory WHY the share price fell to 0.48p - Co needed MONEY to CONTINUE for the immediate future. 2) The co wanted to SELL the co but decided it could NOT recommend any of the parties. People must have panicked at that stage.
-----------------------------------------------------------------------------------------------------------------------------------------------------
<><> IMTK 26 July 2018 RNS
Nothing happened from the 5 June 2018 RNS as above, until on 26 July 2018, OUT OF THE BLUE came the Vin Murria news. The share price was around 6p when the RNS hit from recall and it climbed within minutes.

Comment:
Shares dont go up or down in general due to no significant news. Hence, the London Stock Market has a chart entitled: New Analyses which shows the share chart of a co with GREEN arrows or RED arrows. Green is put on the up price and if one put one*s pointer it will give the exact RNS. This follows the accepted Efficient Mkt Theory that price takes in the said news. This is the Official London Stock Exchange page.

So, we are talking of a DIFFERENT TIME.

In the 26 July 2018, it said that VIN MURRIA LOANED THE CO £500,000. Well, from the 5 June 2018 RNS, does it not say that the co needs money to KEEP THE LIGHTS ON?

If anyone did go to Twitter as I suggested one will see that the RNS of 26 July 2018 and 17 Aug 2018: "Controlled INVESTMENT Equity" was turned into "Equity Placing" which are 2 entirely different things. If anyone has been long on the stocks, one knows that the placing bogie man is a standard acorn to spook investors. Just type into Google, Investment Equity and it gives a different meaning. In the case of equity placing, there would be A HUGE AMOUNT OF SHARES that the financial institutions will sell into the market and may in theory cause an overhang as is norm.

So, with Vin Murria, she is 1 PERSON holding the STOCK. Naturally, she wants management control so that she can carry out her plans. There is no stock overhang as such. Moreover, given that the co needs MONEY to KEEP the LIGHTS ON per the said RNS above, surely, no one can expect Vin to PAY the HIGHEST PRICE & do the WORK to build VALUE for free.

Let us hope that all the comments about Vin that are unjustified in light of the above has NOT been read by her. After all, there a

"Horse Hill made headlines in 2016 when short term flow tests delivered COMMERCIALLY Viable Stablised flow rates at 323, 464 & 901 bopd from the Portland, Kimmeridge 3 & 4 Oil Pools respectively. Horse Hill Portland 32mmbbl of oil in place...Excitement comes from the Deeper Kimmeridge where it is estimated there are 9,965 MMBL of oil in place {OIP} & 2 Limestone layers within the zone provide 373 ft of potential oil play. With so much OIL IN PLACE, the POSITIVE FLOW TEST TO-DATE, it is esy to see why excitment is building around Horse Hill."

Ref: "Is it time to buy UKOG plc after their acquisition of a further 7% shareholding in Horse Hill Developments Ltd."- UK Investor, 20 Aug 2018.

<>CEO OF PRIM- 20 Aug 2018 RNS relating to the above sale of their % in Horse Hill to UKOG plc
Quote: "We are expecting Excellent Results from the EWT testing...we believe that should the EWT CONTINUE TO PERFORM AS EXPECTED.."

Conclusion:
Earlier, the Portland info was posted and now the overall picture of Horse Hill with UKOG being the operator.
The Horse Hill EWT [Extended Well Test] started on 18 July 2018 per RNS - a 150 day test in total. So BEFORE XMAS of 2018, the test will end and results known.

UKOG plc was started in 2013 when David Lenigas did an RTO into Sarantel plc, a shell. Please check.

Tues, 21 Aug 2018.